Concept Foundation is happy to announce that Incepta Pharmaceuticals (Bangladesh) has been awarded WHO Prequalification of their intramuscular (IM) depot medroxyprogesterone acetate (DMPA) 150 mg/ml product. The Incepta product adds a second generic DMPA product to the WHO PQ list, alongside Mylan’s product, thereby increasing the volume of quality assured 3 monthly injectable contraception available worldwide
WHO has just prequalified a combination mifepristone-misoprostol (combipack) for medical abortion
A third quality assured, generic DMPA-IM contraceptive product available for procurement
Concept Foundation announces A. Metin Gülmezoglu as its new Executive Director
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial results have been released, finally providing long awaited answers to questions about the relationship between DMPA, the Implant and the Copper IUD and risk of HIV transmission in women.
WHO/UNICEF/UNFPA Joint Statement: Appropriate Storage and Management of Oxytocin – a Key Commodity for Maternal Health
Appropriate Storage and Management of Oxytocin – a Key Commodity for Maternal Health
Access to Quality Assured generic Intramuscular DMPA continues to rise
The International Planned Parenthood Federation today launched www.MedAb.org – the Medical Abortion Commodities Database, which houses information on the availability of quality misoprostol, mifepristone and co-packaged mifepristone and misoprostol (combipacks) at national level.